Stocks · Health care · Pharmaceutical Preparations

BioAge Labs, Inc.

BIOA Clue Score39
United States Fiscal year ends December CIK 0001709941 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Dov A Md Goldstein
23 Apr 2026
Chief Financial Officer
Exercised, kept
3,542
$4.38
$15.51K
Dov A Md Goldstein
1 Mar 2026
Chief Financial Officer
Exercised, kept
3,542
$4.38
$15.51K
Dov A Md Goldstein
1 Feb 2026
Chief Financial Officer
Exercised, kept
3,541
$4.38
$15.51K
Dov A Md Goldstein
16 Jan 2026
Chief Financial Officer
Exercised, kept
3,542
$4.38
$15.51K

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 12
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 219,117
History held since 27 Sep 2024